Chitosan-gentamicin conjugate attenuates heat stress-induced intestinal barrier injury<i> via</i> the TLR4/STAT6/MYLK signaling pathway:<i> In</i><i> vitro</i> and<i> in</i><i> vivo</i> studies
Niu, Xueting, Hu, Canying, Chen, Shengwei, Wen, Jiaying, Liu, Xiaoxi, Yong, Yanhong, Yu, Zhichao, Ma, Xingbin, Li, Chengpeng, Warda, Mohamad, Abd El-Aty, A. M., Gooneratne, Ravi, Ju, Xianghong
Heat stress (HS) has a negative impact on animal health. A modified chitosan-gentamicin conjugate (CS-GT) was prepared to investigate its potential protective effects and mechanism of action on heat stress-induced intestinal mucosa injury in IPEC-J2 cells and mouse 3D intestinal organs in a mouse model. CS-GT significantly (P < 0.01) reversed the decline in transmembrane resistance and increased the FITC-dextran permeability of the IPEC-J2 monolayer fusion epithelium caused by heat stress. Heat stress decreased the expression of the tight binding proteins occludin, claudin1, and claudin2. However, pretreatment with CS-GT significantly increased (P < 0.01) the expression of these tight binding proteins. Mechanistically, CS-GT inhibited the activation of the TLR4/ STAT6/MYLK signaling pathway induced by heat stress. Molecular docking showed that CS-GT can bind effectively with TLR4. In conclusion, CS-GT alleviates heat stress-induced intestinal mucosal damage both in vitro and in vivo. This effect is mediated, at least partly, by the inhibition of the TLR4/STAT6/MYLK signaling pathway and upregulation of tight junction proteins. These findings suggest that CS-GT may have therapeutic potential in the prevention and treatment of heat stress-related intestinal injury.
- Dergi
- CARBOHYDRATE POLYMERS
- Yıl
- 2023
- Cilt
- 321
- ISSN
- 0144-8617
- eISSN
- 1879-1344
- DOI
- 10.1016/j.carbpol.2023.121279
- WoS UID
- WOS:001057260600001